{"id":2031,"date":"2016-10-01T01:00:00","date_gmt":"2016-10-01T00:00:00","guid":{"rendered":"https:\/\/angh.net\/abstracts\/description-de-la-population-incluse-dans-letude-de-surveillance-des-porteurs-inactifs-de-lantigene-hbs-pibac\/"},"modified":"2018-10-20T18:40:19","modified_gmt":"2018-10-20T16:40:19","slug":"description-de-la-population-incluse-dans-letude-de-surveillance-des-porteurs-inactifs-de-lantigene-hbs-pibac","status":"publish","type":"post","link":"https:\/\/angh.net\/abstracts\/description-de-la-population-incluse-dans-letude-de-surveillance-des-porteurs-inactifs-de-lantigene-hbs-pibac\/","title":{"rendered":"Description de la population incluse dans l&rsquo;\u00e9tude de surveillance des porteurs inactifs de l&rsquo;antig\u00e8ne HBs (PIBAC)"},"content":{"rendered":"<p><strong>2016<\/strong><\/p>\n<p><em>Xavier Causse (1), H\u00e9l\u00e8ne Labadie (1), Jean-Fran\u00e7ois Cadranel (1), Gilles Macaigne (1), Hatem Salloum (1), David Zanditenas (1), Jean Henrion (1), Christophe Renou (1), S\u00e9verine Hommel (1), Jean-Pierre Arpurt (1), Isabelle Ollivier (CHU Caen), Solange Bresson (2), Thierry Fontanges (2), Nathalie Boyer (2), Matthieu Schnee (1), Isabelle Rosa (1), Louis Bettan (1), Simonea Cosconea (1), Corinne Castelnau (2), Sylvain Beorchia (2), Fr\u00e9d\u00e9ric Heluwaert (1), Bertrand Hanslik (2), Corinne Bonny (2), Anne-Marie Roque (APHP), ANGH (1) et CREGG (2).<\/em><\/p>\n<p><strong>H\u00e9patologie <\/strong>&#8211; \u00a02016-04-25 &#8211;\u00a0CO &#8211;<\/p>\n<p>________________________________<\/p>\n<p>Pas de r\u00e9sum\u00e9<\/p>\n","protected":false},"excerpt":{"rendered":"<p>2016 Xavier Causse (1), H\u00e9l\u00e8ne Labadie (1), Jean-Fran\u00e7ois Cadranel (1), Gilles Macaigne (1), Hatem Salloum (1), David Zanditenas (1), Jean Henrion (1), Christophe Renou (1), S\u00e9verine Hommel (1), Jean-Pierre Arpurt (1), Isabelle Ollivier (CHU Caen), Solange Bresson (2), Thierry Fontanges (2), Nathalie Boyer (2), Matthieu Schnee (1), Isabelle Rosa (1), Louis Bettan (1), Simonea Cosconea [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_exactmetrics_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0,"footnotes":""},"categories":[3],"tags":[27],"class_list":["post-2031","post","type-post","status-publish","format-standard","hentry","category-hepatologie","tag-27"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Description de la population incluse dans l&#039;\u00e9tude de surveillance des porteurs inactifs de l&#039;antig\u00e8ne HBs (PIBAC) - Abstracts des congr\u00e8s de l&#039;ANGH<\/title>\n<meta name=\"description\" content=\"ANGH R\u00e9sum\u00e9s congr\u00e8s H\u00e9patologie Gastroent\u00e9romogie Hepatology Gastroenterology Etudes cliniques Clinical study\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/angh.net\/abstracts\/description-de-la-population-incluse-dans-letude-de-surveillance-des-porteurs-inactifs-de-lantigene-hbs-pibac\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Description de la population incluse dans l&#039;\u00e9tude de surveillance des porteurs inactifs de l&#039;antig\u00e8ne HBs (PIBAC) - Abstracts des congr\u00e8s de l&#039;ANGH\" \/>\n<meta property=\"og:description\" content=\"ANGH R\u00e9sum\u00e9s congr\u00e8s H\u00e9patologie Gastroent\u00e9romogie Hepatology Gastroenterology Etudes cliniques Clinical study\" \/>\n<meta property=\"og:url\" content=\"https:\/\/angh.net\/abstracts\/description-de-la-population-incluse-dans-letude-de-surveillance-des-porteurs-inactifs-de-lantigene-hbs-pibac\/\" \/>\n<meta property=\"og:site_name\" content=\"Abstracts des congr\u00e8s de l&#039;ANGH\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ANGH-2136322560030484\/\" \/>\n<meta property=\"article:published_time\" content=\"2016-10-01T00:00:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2018-10-20T16:40:19+00:00\" \/>\n<meta name=\"author\" content=\"abstracts\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"abstracts\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/angh.net\/abstracts\/description-de-la-population-incluse-dans-letude-de-surveillance-des-porteurs-inactifs-de-lantigene-hbs-pibac\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/angh.net\/abstracts\/description-de-la-population-incluse-dans-letude-de-surveillance-des-porteurs-inactifs-de-lantigene-hbs-pibac\/\"},\"author\":{\"name\":\"abstracts\",\"@id\":\"https:\/\/angh.net\/abstracts\/#\/schema\/person\/f532083854369dca4b9f509cfbad90e1\"},\"headline\":\"Description de la population incluse dans l&rsquo;\u00e9tude de surveillance des porteurs inactifs de l&rsquo;antig\u00e8ne HBs (PIBAC)\",\"datePublished\":\"2016-10-01T00:00:00+00:00\",\"dateModified\":\"2018-10-20T16:40:19+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/angh.net\/abstracts\/description-de-la-population-incluse-dans-letude-de-surveillance-des-porteurs-inactifs-de-lantigene-hbs-pibac\/\"},\"wordCount\":91,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/angh.net\/abstracts\/#organization\"},\"keywords\":[\"2016\"],\"articleSection\":[\"Hepatologie\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/angh.net\/abstracts\/description-de-la-population-incluse-dans-letude-de-surveillance-des-porteurs-inactifs-de-lantigene-hbs-pibac\/\",\"url\":\"https:\/\/angh.net\/abstracts\/description-de-la-population-incluse-dans-letude-de-surveillance-des-porteurs-inactifs-de-lantigene-hbs-pibac\/\",\"name\":\"Description de la population incluse dans l'\u00e9tude de surveillance des porteurs inactifs de l'antig\u00e8ne HBs (PIBAC) - Abstracts des congr\u00e8s de l&#039;ANGH\",\"isPartOf\":{\"@id\":\"https:\/\/angh.net\/abstracts\/#website\"},\"datePublished\":\"2016-10-01T00:00:00+00:00\",\"dateModified\":\"2018-10-20T16:40:19+00:00\",\"description\":\"ANGH R\u00e9sum\u00e9s congr\u00e8s H\u00e9patologie Gastroent\u00e9romogie Hepatology Gastroenterology Etudes cliniques Clinical study\",\"breadcrumb\":{\"@id\":\"https:\/\/angh.net\/abstracts\/description-de-la-population-incluse-dans-letude-de-surveillance-des-porteurs-inactifs-de-lantigene-hbs-pibac\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/angh.net\/abstracts\/description-de-la-population-incluse-dans-letude-de-surveillance-des-porteurs-inactifs-de-lantigene-hbs-pibac\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/angh.net\/abstracts\/description-de-la-population-incluse-dans-letude-de-surveillance-des-porteurs-inactifs-de-lantigene-hbs-pibac\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/angh.net\/abstracts\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Description de la population incluse dans l&rsquo;\u00e9tude de surveillance des porteurs inactifs de l&rsquo;antig\u00e8ne HBs (PIBAC)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/angh.net\/abstracts\/#website\",\"url\":\"https:\/\/angh.net\/abstracts\/\",\"name\":\"Abstracts des congr\u00e8s de l&#039;ANGH\",\"description\":\"Base de donn\u00e9es des abstracts du congr\u00e8s depuis 2003\",\"publisher\":{\"@id\":\"https:\/\/angh.net\/abstracts\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/angh.net\/abstracts\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/angh.net\/abstracts\/#organization\",\"name\":\"ANGH\",\"url\":\"https:\/\/angh.net\/abstracts\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/angh.net\/abstracts\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/angh.net\/abstracts\/wp-content\/uploads\/sites\/2\/2018\/10\/logo_angh_2018_-48px.jpg\",\"contentUrl\":\"https:\/\/angh.net\/abstracts\/wp-content\/uploads\/sites\/2\/2018\/10\/logo_angh_2018_-48px.jpg\",\"width\":48,\"height\":18,\"caption\":\"ANGH\"},\"image\":{\"@id\":\"https:\/\/angh.net\/abstracts\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/ANGH-2136322560030484\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/angh.net\/abstracts\/#\/schema\/person\/f532083854369dca4b9f509cfbad90e1\",\"name\":\"abstracts\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/2bb25d9cedd377e33f0ebc4fb5994a2f9d3e02f897704acdcc173c15b7c75253?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/2bb25d9cedd377e33f0ebc4fb5994a2f9d3e02f897704acdcc173c15b7c75253?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/2bb25d9cedd377e33f0ebc4fb5994a2f9d3e02f897704acdcc173c15b7c75253?s=96&d=mm&r=g\",\"caption\":\"abstracts\"},\"url\":\"https:\/\/angh.net\/abstracts\/author\/abstracts\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Description de la population incluse dans l'\u00e9tude de surveillance des porteurs inactifs de l'antig\u00e8ne HBs (PIBAC) - Abstracts des congr\u00e8s de l&#039;ANGH","description":"ANGH R\u00e9sum\u00e9s congr\u00e8s H\u00e9patologie Gastroent\u00e9romogie Hepatology Gastroenterology Etudes cliniques Clinical study","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/angh.net\/abstracts\/description-de-la-population-incluse-dans-letude-de-surveillance-des-porteurs-inactifs-de-lantigene-hbs-pibac\/","og_locale":"fr_FR","og_type":"article","og_title":"Description de la population incluse dans l'\u00e9tude de surveillance des porteurs inactifs de l'antig\u00e8ne HBs (PIBAC) - Abstracts des congr\u00e8s de l&#039;ANGH","og_description":"ANGH R\u00e9sum\u00e9s congr\u00e8s H\u00e9patologie Gastroent\u00e9romogie Hepatology Gastroenterology Etudes cliniques Clinical study","og_url":"https:\/\/angh.net\/abstracts\/description-de-la-population-incluse-dans-letude-de-surveillance-des-porteurs-inactifs-de-lantigene-hbs-pibac\/","og_site_name":"Abstracts des congr\u00e8s de l&#039;ANGH","article_publisher":"https:\/\/www.facebook.com\/ANGH-2136322560030484\/","article_published_time":"2016-10-01T00:00:00+00:00","article_modified_time":"2018-10-20T16:40:19+00:00","author":"abstracts","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"abstracts"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/angh.net\/abstracts\/description-de-la-population-incluse-dans-letude-de-surveillance-des-porteurs-inactifs-de-lantigene-hbs-pibac\/#article","isPartOf":{"@id":"https:\/\/angh.net\/abstracts\/description-de-la-population-incluse-dans-letude-de-surveillance-des-porteurs-inactifs-de-lantigene-hbs-pibac\/"},"author":{"name":"abstracts","@id":"https:\/\/angh.net\/abstracts\/#\/schema\/person\/f532083854369dca4b9f509cfbad90e1"},"headline":"Description de la population incluse dans l&rsquo;\u00e9tude de surveillance des porteurs inactifs de l&rsquo;antig\u00e8ne HBs (PIBAC)","datePublished":"2016-10-01T00:00:00+00:00","dateModified":"2018-10-20T16:40:19+00:00","mainEntityOfPage":{"@id":"https:\/\/angh.net\/abstracts\/description-de-la-population-incluse-dans-letude-de-surveillance-des-porteurs-inactifs-de-lantigene-hbs-pibac\/"},"wordCount":91,"commentCount":0,"publisher":{"@id":"https:\/\/angh.net\/abstracts\/#organization"},"keywords":["2016"],"articleSection":["Hepatologie"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/angh.net\/abstracts\/description-de-la-population-incluse-dans-letude-de-surveillance-des-porteurs-inactifs-de-lantigene-hbs-pibac\/","url":"https:\/\/angh.net\/abstracts\/description-de-la-population-incluse-dans-letude-de-surveillance-des-porteurs-inactifs-de-lantigene-hbs-pibac\/","name":"Description de la population incluse dans l'\u00e9tude de surveillance des porteurs inactifs de l'antig\u00e8ne HBs (PIBAC) - Abstracts des congr\u00e8s de l&#039;ANGH","isPartOf":{"@id":"https:\/\/angh.net\/abstracts\/#website"},"datePublished":"2016-10-01T00:00:00+00:00","dateModified":"2018-10-20T16:40:19+00:00","description":"ANGH R\u00e9sum\u00e9s congr\u00e8s H\u00e9patologie Gastroent\u00e9romogie Hepatology Gastroenterology Etudes cliniques Clinical study","breadcrumb":{"@id":"https:\/\/angh.net\/abstracts\/description-de-la-population-incluse-dans-letude-de-surveillance-des-porteurs-inactifs-de-lantigene-hbs-pibac\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/angh.net\/abstracts\/description-de-la-population-incluse-dans-letude-de-surveillance-des-porteurs-inactifs-de-lantigene-hbs-pibac\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/angh.net\/abstracts\/description-de-la-population-incluse-dans-letude-de-surveillance-des-porteurs-inactifs-de-lantigene-hbs-pibac\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/angh.net\/abstracts\/"},{"@type":"ListItem","position":2,"name":"Description de la population incluse dans l&rsquo;\u00e9tude de surveillance des porteurs inactifs de l&rsquo;antig\u00e8ne HBs (PIBAC)"}]},{"@type":"WebSite","@id":"https:\/\/angh.net\/abstracts\/#website","url":"https:\/\/angh.net\/abstracts\/","name":"Abstracts des congr\u00e8s de l&#039;ANGH","description":"Base de donn\u00e9es des abstracts du congr\u00e8s depuis 2003","publisher":{"@id":"https:\/\/angh.net\/abstracts\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/angh.net\/abstracts\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/angh.net\/abstracts\/#organization","name":"ANGH","url":"https:\/\/angh.net\/abstracts\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/angh.net\/abstracts\/#\/schema\/logo\/image\/","url":"https:\/\/angh.net\/abstracts\/wp-content\/uploads\/sites\/2\/2018\/10\/logo_angh_2018_-48px.jpg","contentUrl":"https:\/\/angh.net\/abstracts\/wp-content\/uploads\/sites\/2\/2018\/10\/logo_angh_2018_-48px.jpg","width":48,"height":18,"caption":"ANGH"},"image":{"@id":"https:\/\/angh.net\/abstracts\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ANGH-2136322560030484\/"]},{"@type":"Person","@id":"https:\/\/angh.net\/abstracts\/#\/schema\/person\/f532083854369dca4b9f509cfbad90e1","name":"abstracts","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/2bb25d9cedd377e33f0ebc4fb5994a2f9d3e02f897704acdcc173c15b7c75253?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/2bb25d9cedd377e33f0ebc4fb5994a2f9d3e02f897704acdcc173c15b7c75253?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/2bb25d9cedd377e33f0ebc4fb5994a2f9d3e02f897704acdcc173c15b7c75253?s=96&d=mm&r=g","caption":"abstracts"},"url":"https:\/\/angh.net\/abstracts\/author\/abstracts\/"}]}},"_links":{"self":[{"href":"https:\/\/angh.net\/abstracts\/wp-json\/wp\/v2\/posts\/2031","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/angh.net\/abstracts\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/angh.net\/abstracts\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/angh.net\/abstracts\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/angh.net\/abstracts\/wp-json\/wp\/v2\/comments?post=2031"}],"version-history":[{"count":0,"href":"https:\/\/angh.net\/abstracts\/wp-json\/wp\/v2\/posts\/2031\/revisions"}],"wp:attachment":[{"href":"https:\/\/angh.net\/abstracts\/wp-json\/wp\/v2\/media?parent=2031"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/angh.net\/abstracts\/wp-json\/wp\/v2\/categories?post=2031"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/angh.net\/abstracts\/wp-json\/wp\/v2\/tags?post=2031"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}